Genmab A/S
GMAB · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $7,844,000 | $5,637,000 | $7,035,000 | $3,983,000 |
| Dep. & Amort. | $413,000 | $295,000 | $362,000 | $248,000 |
| Deferred Tax | $0 | $122,000 | $0 | -$546,000 |
| Stock-Based Comp. | $721,000 | $586,000 | $439,000 | $310,000 |
| Change in WC | -$1,595,000 | $1,362,000 | -$1,930,000 | -$770,000 |
| Other Non-Cash | $388,000 | -$622,000 | -$1,994,000 | -$997,000 |
| Operating Cash Flow | $7,771,000 | $7,380,000 | $3,912,000 | $2,228,000 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$187,000 | -$366,000 | -$317,000 | -$252,000 |
| Net Acquisitions | -$12,246,000 | $0 | $2,444,000 | $709,000 |
| Inv. Purchases | -$8,636,000 | -$10,907,000 | -$9,698,000 | -$15,616,000 |
| Inv. Sales/Matur. | $11,279,000 | $10,001,000 | $7,254,000 | $14,907,000 |
| Other Inv. Act. | -$117,000 | -$10,000 | -$2,444,000 | -$709,000 |
| Investing Cash Flow | -$9,907,000 | -$1,282,000 | -$2,761,000 | -$961,000 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$60,000 | -$91,000 | -$73,000 | -$58,000 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | -$3,988,000 | -$564,000 | -$908,000 | -$447,000 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $129,000 | $49,000 | $192,000 | $85,000 |
| Financing Cash Flow | -$3,919,000 | -$606,000 | -$789,000 | -$420,000 |
| Forex Effect | $1,046,000 | -$518,000 | $574,000 | $850,000 |
| Net Chg. in Cash | -$5,009,000 | $4,974,000 | $936,000 | $1,697,000 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $14,867,000 | $9,893,000 | $8,957,000 | $7,260,000 |
| End Cash | $9,858,000 | $14,867,000 | $9,893,000 | $8,957,000 |
| Free Cash Flow | $7,584,000 | $7,004,000 | $3,595,000 | $1,976,000 |